Ellis L Reinherz

Dana-Farber Cancer Institute

NIH Rank #5441
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#5,441
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2M across 3 grants · National rank #5441.

Top grants by award amount

Ellis L Reinherz's NIH grant portfolio, ranked by award amount.

  • 1P01AI181597-01P01
    RNA-based HIV-1 chimera vaccines encoding a trimerizing host self-protein protomer linked to a viral MPER-TM segment
    $940.6K
    award amount
  • 5R01CA265928-03R01
    A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
    $640.5K
    award amount
  • 5P01AI143565-05P01
    Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineage
    $400.2K
    award amount

Affiliation

Institutions that have administered grants for Ellis L Reinherz.

Affiliated with Dana-Farber Cancer Institute (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Dana-Farber Cancer Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5441